SCHEMBL30729195

SCHEMBL30729195

Cc1n[nH]c2ccc(N(C)C3CCOCC3)nc12

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PDE6D O43924 1/20 0.40
▸ PDE6A P16499 1/20 0.40
▸ PDE6G P18545 1/20 0.40
▸ PDE6B P35913 1/20 0.40
▸ PDE6C P51160 1/20 0.40
▸ PDE6H Q13956 1/20 0.40
▸ PDE10A Q9Y233 1/20 0.40
▸ GSK3B P49841 2/20 0.34
▸ GSK3A P49840 1/20 0.34
▸ ALDH1A1 P00352 1/20 0.33
▸ ACACB O00763 1/20 0.33
▸ LMNA P02545 1/20 0.33
▸ SMN1; SMN2 Q16637 1/20 0.33
▸ GRM4 Q14833 5/20 0.32
▸ ATR Q13535 1/20 0.32
▸ ATRIP Q8WXE1 1/20 0.32
▸ LRRK2 Q5S007 3/20 0.32
▸ EGLN1 Q9GZT9 1/20 0.32
▸ KCNH2 Q12809 1/20 0.31
▸ ITK Q08881 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27075014 1.00 PDE6D (0.40) PDE6DPDE6APDE6GPDE6BPDE6C
SCHEMBL27074823 0.79 FGFR1 (0.39) PDE6DPDE6APDE6GPDE6BPDE6C
SCHEMBL27074745 0.78 PDE10A (0.37) PDE6DPDE6APDE6GPDE6BPDE6C
SCHEMBL27074906 0.76 PDE10A (0.38) PDE6DPDE6APDE6GPDE6BPDE6C
SCHEMBL27074723 0.76 PDE6D (0.38) PDE6DPDE6APDE6GPDE6BPDE6C
SCHEMBL27074696 0.76 PDE10A (0.38) PDE6DPDE6APDE6GPDE6BPDE6C
SCHEMBL27075031 0.73 PDE6D (0.37) PDE6DPDE6APDE6GPDE6BPDE6C
SCHEMBL30729184 0.73 PDE6D (0.37) PDE6DPDE6APDE6GPDE6BPDE6C
SCHEMBL30729191 0.72 LRRK2 (0.35) PDE6DPDE6APDE6GPDE6BPDE6C
SCHEMBL27074802 0.72 LRRK2 (0.35) PDE6DPDE6APDE6GPDE6BPDE6C

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240034736-A1 HSD17B13 INHIBITORS AND USES THEREOF FL2022-001, INC. 2024-02-01 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240034736-A1 HSD17B13 INHIBITORS AND USES THEREOF HSD17B3, HSD17B11, HSD17B1 PDE6D 2802/4885PDE6A 2663/4885PDE6G 1825/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback